Trials / Withdrawn
WithdrawnNCT03401580
Efficacy of Fixed-doses of Antihypertensive and Statin Drugs
Clinical Trial to Compare the Efficacy and Safety of Fixed-doses of VIENA II in Participants With Hypertension and Dyslipidemia
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of different fixed-dose combination of Viena II in treatment of hypertension and dyslipidemia.
Detailed description
* Fase II, national, multicenter, randomized, double-blind. * Maximal duration: 8 weeks; * 04 visits; * Safety and efficacy evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viena II 160/10 | once daily |
| DRUG | Viena II 190/10 | once daily |
| DRUG | Viena II 160/12 | once daily |
| DRUG | Viena II 190/12 | once daily |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-07-01
- Completion
- 2019-09-01
- First posted
- 2018-01-17
- Last updated
- 2019-10-16
Source: ClinicalTrials.gov record NCT03401580. Inclusion in this directory is not an endorsement.